Cleo-Aron Weis Selected Research

Skin Neoplasms (Skin Cancer)

1/2018

Merkel cell carcinoma expresses the immunoregulatory ligand CD200 and induces immunosuppressive macrophages and regulatory T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cleo-Aron Weis Research Topics

Disease

17	Neoplasms (Cancer) 05/2023 - 01/2015
7	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 10/2016
5	Carcinoma (Carcinomatosis) 01/2022 - 12/2018
5	Colorectal Neoplasms (Colorectal Cancer) 07/2019 - 01/2017
4	Myasthenia Gravis 05/2018 - 08/2015
3	Neoplasm Metastasis (Metastasis) 06/2021 - 01/2017
3	Thymoma (Thymic Carcinoma) 01/2021 - 02/2015
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2022
2	Non-Muscle Invasive Bladder Neoplasms 01/2022 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 06/2020 - 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2023
1	Squamous Cell Carcinoma of Head and Neck 09/2023
1	Breast Neoplasms (Breast Cancer) 08/2021
1	Follicular Adenocarcinoma 08/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Pancreatitis 01/2021
1	Hyperplasia 06/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Carcinoid Tumor (Carcinoid) 01/2019
1	Adenocarcinoma 01/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Lymphatic Metastasis 12/2018
1	Merkel Cell Carcinoma 01/2018
1	Skin Neoplasms (Skin Cancer) 01/2018
1	Melanoma (Melanoma, Malignant) 11/2017
1	Microvillus inclusion disease 07/2014

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2017
5	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
3	margatoxinIBA 05/2018 - 01/2018
3	Cholinergic ReceptorsIBA 05/2018 - 08/2015
2	Cisplatin (Platino)FDA LinkGeneric 09/2023 - 04/2021
2	Coloring Agents (Dyes)IBA 08/2021 - 01/2015
2	RNA (Ribonucleic Acid)IBA 04/2021 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2021 - 05/2018
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2018
2	ParaffinIBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 11/2017
1	Caspase 3 (Caspase-3)IBA 09/2023
1	Cetuximab (Erbitux)FDA Link 09/2023
1	cyclopropapyrroloindoleIBA 09/2023
1	Tissue ExtractsIBA 05/2023
1	Azacitidine (5 Azacytidine)FDA Link 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	eltrombopag FDA Link 01/2022
1	1,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA 06/2021
1	galactosylceramide sulfotransferaseIBA 01/2021
1	Interleukin-22 (IL-22)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	Long Noncoding RNAIBA 12/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 06/2020
1	Microfilament Proteins (Actin Binding Proteins)IBA 11/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019
1	Bevacizumab (Avastin)FDA Link 07/2019
1	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 07/2019
1	SteroidsIBA 02/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	ChromograninsIBA 01/2019
1	SynaptophysinIBA 01/2019
1	Chromogranin AIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 12/2018
1	Keratins (Keratin)IBA 08/2018
1	AntibodiesIBA 05/2018
1	LigandsIBA 01/2018
1	Fibroblast Growth Factor 3IBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	Hyaluronic Acid (Hyaluronan)IBA 11/2017
1	CytokinesIBA 11/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2017
1	Peptide Hydrolases (Proteases)FDA Link 11/2017
1	Peptide Elongation Factor 1 (EF-1)IBA 09/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Sunitinib (Sutent)FDA Link 02/2015
1	A-factor (Streptomyces)IBA 01/2015
1	Qa-SNARE Proteins (Syntaxin)IBA 07/2014

Therapy/Procedure

8	Therapeutics 09/2023 - 01/2017
7	Cystectomy 01/2022 - 10/2016
4	Immunotherapy 01/2019 - 11/2017
3	Drug Therapy (Chemotherapy) 04/2021 - 01/2017
3	Thymectomy 05/2018 - 01/2018
2	Radiotherapy 09/2023 - 06/2021
1	Radioimmunotherapy 09/2023
1	Chemoradiotherapy 09/2023
1	Heterologous Transplantation (Xenotransplantation) 01/2022
1	Prostatectomy (Retropubic Prostatectomy) 06/2020
1	Intravenous Administration 01/2018
1	Castration 03/2017
1	Transplantation 08/2015